Home/Pipeline/Stroke Biomarker

Stroke Biomarker

Stroke Assessment

Pre-clinicalActive

Key Facts

Indication
Stroke Assessment
Phase
Pre-clinical
Status
Active
Company

About BrainScope

BrainScope is a pioneering neurodiagnostics company that has commercialized the first FDA-cleared AI/ML-enabled medical device in neurology for head injury assessment. Its core technology is a proprietary platform that applies computational neuroscience and machine learning to EEG data to generate rapid, objective biomarkers. The company has demonstrated clinical utility in emergency settings, reducing unnecessary CT scans and patient length of stay, and is now leveraging its 'Large Neural Model Platform' to develop biomarkers for a broader range of CNS disorders.

View full company profile